JVMAX | NBRTX | JVMAX / NBRTX | |
Total Expense Ratio | 1.12 | 0.85 | 132% |
Annual Report Gross Expense Ratio | 1.13 | 1.36 | 83% |
Fund Existence | 28 years | 15 years | - |
Gain YTD | -8.576 | -15.244 | 56% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 19.4B | 45M | 43,111% |
Annual Yield % from dividends | 0.61 | 0.77 | 79% |
Returns for 1 year | -11.80 | -11.55 | 102% |
Returns for 3 years | -9.16 | -12.55 | 73% |
Returns for 5 years | 45.43 | 68.35 | 66% |
Returns for 10 years | 18.32 | 2.25 | 816% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 24.36 | 0.35 | +1.46% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PGZ | 10.13 | 0.12 | +1.20% |
PRINCIPAL REAL ESTATE Income FUND | |||
PFM | 43.48 | 0.24 | +0.56% |
Invesco Dividend Achievers™ ETF | |||
ISTB | 48.22 | N/A | +0.01% |
iShares Core 1-5 Year USD Bond ETF | |||
AMZY | 14.47 | -0.45 | -3.02% |
YieldMax AMZN Option Income Strategy ETF |